Teva Valsartan Product Recall (2018-07-09)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| K44166, K45371 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| D. ACT-Valsartan 320mg Tablet | Tablet | DIN 02337517 | Valsartan 320mg |
| 35212731R | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| E. Teva-Valsartan / HCTZ Tablet | Tablet | DIN 02357046 | Valsartan 320mg |
| K45370, K47652, K47653, K47654 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| B. ACT-Valsartan 80mg Tablet | Tablet | DIN 02337495 | Valsartan 80mg |
| K44167, K39691, K47657, K47658 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| C. ACT-Valsartan 160mg Tablet | Tablet | DIN 02337509 | Valsartan 160mg |
| K47338 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| ACT-Valsartan 40mg Tablet | Tablet | DIN 02337487 | Valsartan 40mg |
Recalled Products
-
ACT-Valsartan 40mg Tablet
-
ACT-Valsartan 80mg Tablet
-
ACT-Valsartan 160mg Tablet
-
ACT-Valsartan 320mg Tablet
-
Teva-Valsartan / HCTZ Tablet
Affected lots may be manufactured with an API containing a contaminant.
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67202a-eng.php